S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
The Next Stage Of Google’s Rally Just Started
The Real Reason They Murdered JFK? (Ad)
CarMax Slides On Earnings Disappointment, Time To Celebrate?
Will the Energy Sector Continue to Outshine the Market?
Better Than Oil Stocks? (Ad)
In a good sign for China's struggling economy, factory activity grows for the first time in 6 months
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
Better Than Oil Stocks? (Ad)
Nike, Amicus Therapeutics rise; Vail Resorts, Hess fall, Friday, 9/29/2023
How major US stock indexes fared Friday, 9/29/2023
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
The Next Stage Of Google’s Rally Just Started
The Real Reason They Murdered JFK? (Ad)
CarMax Slides On Earnings Disappointment, Time To Celebrate?
Will the Energy Sector Continue to Outshine the Market?
Better Than Oil Stocks? (Ad)
In a good sign for China's struggling economy, factory activity grows for the first time in 6 months
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
Better Than Oil Stocks? (Ad)
Nike, Amicus Therapeutics rise; Vail Resorts, Hess fall, Friday, 9/29/2023
How major US stock indexes fared Friday, 9/29/2023
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
The Next Stage Of Google’s Rally Just Started
The Real Reason They Murdered JFK? (Ad)
CarMax Slides On Earnings Disappointment, Time To Celebrate?
Will the Energy Sector Continue to Outshine the Market?
Better Than Oil Stocks? (Ad)
In a good sign for China's struggling economy, factory activity grows for the first time in 6 months
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
Better Than Oil Stocks? (Ad)
Nike, Amicus Therapeutics rise; Vail Resorts, Hess fall, Friday, 9/29/2023
How major US stock indexes fared Friday, 9/29/2023
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
The Next Stage Of Google’s Rally Just Started
The Real Reason They Murdered JFK? (Ad)
CarMax Slides On Earnings Disappointment, Time To Celebrate?
Will the Energy Sector Continue to Outshine the Market?
Better Than Oil Stocks? (Ad)
In a good sign for China's struggling economy, factory activity grows for the first time in 6 months
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
Better Than Oil Stocks? (Ad)
Nike, Amicus Therapeutics rise; Vail Resorts, Hess fall, Friday, 9/29/2023
How major US stock indexes fared Friday, 9/29/2023
Positive News SentimentPositive News
NASDAQ:ALPN

Alpine Immune Sciences (ALPN) News Today

$11.45
+0.16 (+1.42%)
(As of 09/29/2023 ET)
Compare
Today's Range
$11.30
▼
$11.58
50-Day Range
$11.29
▼
$13.98
52-Week Range
$4.82
▼
$14.92
Volume
404,035 shs
Average Volume
253,745 shs
Market Capitalization
$563.34 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$18.00
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media
SourceHeadline
msn.com logoHere's Why You Should Invest in Alpine (ALPN) Stock Now
msn.com - September 20 at 2:52 AM
markets.businessinsider.com logoH.C. Wainwright Keeps Their Buy Rating on Alpine Immune Sciences (ALPN)
markets.businessinsider.com - September 13 at 8:33 AM
finance.yahoo.com logoAlpine Immune Sciences Presents First Preclinical Data for Povetacicept in Myasthenia Gravis at the American Neurological Association Annual Meeting
finance.yahoo.com - September 12 at 5:29 PM
marketbeat.com logoGreat Point Partners LLC Raises Stock Position in Alpine Immune Sciences, Inc. (NASDAQ:ALPN)
marketbeat.com - September 12 at 10:12 AM
finance.yahoo.com logoAlpine Immune Sciences to Present First Preclinical Data for Povetacicept in Myasthenia Gravis at the American Neurological Association Annual Meeting
finance.yahoo.com - September 5 at 8:57 AM
marketbeat.com logoAlpine Immune Sciences (NASDAQ:ALPN) Earns "Outperform" Rating from Wedbush
marketbeat.com - September 1 at 4:40 PM
markets.businessinsider.com logoAnalyst Expectations for Alpine Immune Sciences's Future
markets.businessinsider.com - August 31 at 7:46 PM
msn.com logoAlpine Immune Sciences (ALPN) Price Target Increased by 10.67% to 16.93
msn.com - August 31 at 7:15 AM
finance.yahoo.com logoAlpine Immune Sciences Announces Initiation of Dosing in 240 mg IgA Nephropathy Cohort of Povetacicept Clinical Study (RUBY-3)
finance.yahoo.com - August 30 at 9:15 PM
finance.yahoo.com logoAlpine Immune Sciences, Inc. (ALPN) Is a Great Choice for 'Trend' Investors, Here's Why
finance.yahoo.com - August 24 at 2:30 PM
finance.yahoo.com logoAlpine Immune Sciences Announces Appointment of M. Christina Yi as Chief Technology Officer and Grant under Nasdaq Listing Rule 5635(c)
finance.yahoo.com - August 22 at 5:58 PM
finance.yahoo.com logoDoes Alpine Immune Sciences, Inc. (ALPN) Have the Potential to Rally 25.38% as Wall Street Analysts Expect?
finance.yahoo.com - August 17 at 5:27 PM
msn.com logoAlpine Immune Sciences: Going Strong But For How Long?
msn.com - August 16 at 5:41 PM
finance.yahoo.com logoCompanies Like Alpine Immune Sciences (NASDAQ:ALPN) Are In A Position To Invest In Growth
finance.yahoo.com - August 16 at 8:27 AM
marketbeat.com logoSG Americas Securities LLC Acquires New Shares in Alpine Immune Sciences, Inc. (NASDAQ:ALPN)
marketbeat.com - August 16 at 4:07 AM
msn.com logoHC Wainwright & Co. Maintains Alpine Immune Sciences (ALPN) Buy Recommendation
msn.com - August 15 at 5:25 PM
msn.com logoWedbush Maintains Alpine Immune Sciences (ALPN) Outperform Recommendation
msn.com - August 15 at 5:25 PM
finance.yahoo.com logoAlpine Immune Sciences Reports Second Quarter 2023 Financial Results
finance.yahoo.com - August 14 at 7:43 PM
finance.yahoo.com logoAlpine Immune Sciences, Inc. (NASDAQ:ALPN) surges 14%; private equity firms who own 38% shares profited along with institutions
finance.yahoo.com - July 23 at 2:12 PM
marketbeat.com logoAlpine Immune Sciences, Inc. (NASDAQ:ALPN) Short Interest Up 26.4% in June
marketbeat.com - July 17 at 3:23 AM
finance.yahoo.com logoAlpine Immune (ALPN) Stock Up 19% MTD, Will the Uptick Continue?
finance.yahoo.com - June 22 at 12:45 PM
marketbeat.com logoMetLife Investment Management LLC Purchases New Shares in Alpine Immune Sciences, Inc. (NASDAQ:ALPN)
marketbeat.com - June 21 at 4:41 AM
markets.businessinsider.com logoAlpine Immune Sciences (ALPN) Receives a Rating Update from a Top Analyst
markets.businessinsider.com - June 14 at 7:34 AM
marketbeat.com logoAvidity Partners Management LP Has $7.56 Million Stake in Alpine Immune Sciences, Inc. (NASDAQ:ALPN)
marketbeat.com - June 14 at 5:27 AM
fool.com logoAlpine Immune Sciences (NASDAQ: ALPN)
fool.com - June 10 at 10:48 AM
finance.yahoo.com logoAlpine Immune Sciences to Present Data from RUBY-1, a Phase 1 Study of Povetacicept, at Upcoming Scientific Congresses
finance.yahoo.com - May 19 at 7:37 PM
msn.com logoAlpine Immune Sciences GAAP EPS of -$0.28 beats by $0.09, revenue of $9.4M beats by $2.52M
msn.com - May 13 at 3:58 PM
msn.com logoHC Wainwright & Co. Reiterates Alpine Immune Sciences (ALPN) Buy Recommendation
msn.com - May 12 at 7:23 PM
msn.com logoRecap: Alpine Immune Sciences Q1 Earnings
msn.com - May 11 at 9:45 PM
finance.yahoo.com logoAlpine Immune Sciences Reports First Quarter 2023 Financial Results
finance.yahoo.com - May 11 at 4:45 PM
finance.yahoo.com logoPinning Down Alpine Immune Sciences, Inc.'s (NASDAQ:ALPN) P/S Is Difficult Right Now
finance.yahoo.com - May 5 at 8:36 AM
finance.yahoo.com logoAlpine Immune Sciences Announces Participation in the Bank of America Securities Healthcare Conference
finance.yahoo.com - May 1 at 7:43 PM
marketbeat.com logoAlpine Immune Sciences, Inc. (NASDAQ:ALPN) Shares Sold by Allspring Global Investments Holdings LLC
marketbeat.com - April 23 at 4:02 AM
marketbeat.com logoAlpine Immune Sciences, Inc. (NASDAQ:ALPN) Sees Large Increase in Short Interest
marketbeat.com - April 19 at 4:56 AM
seekingalpha.com logoAlpine Immune: Rebuilding Itself From Scratch, But Long Way To Go Before Proof
seekingalpha.com - March 29 at 7:37 AM
finance.yahoo.com logoAlpine Immune Sciences, Inc. (NASDAQ:ALPN) Q4 2022 Earnings Call Transcript
finance.yahoo.com - March 27 at 10:30 AM
finance.yahoo.com logoEven though Alpine Immune Sciences (NASDAQ:ALPN) has lost US$39m market cap in last 7 days, shareholders are still up 200% over 3 years
finance.yahoo.com - March 27 at 10:30 AM
marketbeat.com logoAlpine Immune Sciences, Inc. to Post Q1 2024 Earnings of ($0.41) Per Share, Oppenheimer Forecasts (NASDAQ:ALPN)
marketbeat.com - March 27 at 2:38 AM
benzinga.com logoAlpine Immune Sciences Stock (NASDAQ:ALPN), Dividends
benzinga.com - March 25 at 3:58 PM
msn.com logoAlpine Immune Sciences's Return On Capital Employed Insights
msn.com - March 24 at 2:52 PM
finance.yahoo.com logoQ4 2022 Alpine Immune Sciences Inc Earnings Call
finance.yahoo.com - March 24 at 2:52 PM
finance.yahoo.com logoAlpine Immune Sciences, Inc. (ALPN) Reports Q4 Loss, Lags Revenue Estimates
finance.yahoo.com - March 23 at 11:50 PM
finance.yahoo.com logoAlpine Immune Sciences Provides Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results
finance.yahoo.com - March 23 at 6:46 PM
msn.com logoEarnings Preview: Alpine Immune Sciences
msn.com - March 22 at 3:00 PM
finance.yahoo.com logoAlpine Immune Sciences to Present Povetacicept (ALPN-303) Phase 1 (RUBY-1) Study Data and Clinical Pharmacokinetic & Pharmacodynamic Modeling at Upcoming Scientific Conferences
finance.yahoo.com - March 20 at 7:48 PM
finance.yahoo.com logoAlpine Immune Sciences to Present Povetacicept (ALPN-303) Phase 1 (RUBY-1) Study Data at the 2023 American Academy of Dermatology Annual Meeting
finance.yahoo.com - March 16 at 7:55 PM
finance.yahoo.com logoAlpine Immune Sciences to Report Fourth Quarter and Full Year 2022 Financial Results
finance.yahoo.com - March 15 at 8:18 PM
finance.yahoo.com logoAlpine Immune Sciences to Participate in Two Upcoming Healthcare Conferences
finance.yahoo.com - March 1 at 10:21 AM
marketbeat.com logoLynx1 Capital Management LP Purchases 1,129,551 Shares of Alpine Immune Sciences, Inc. (NASDAQ:ALPN)
marketbeat.com - February 24 at 1:37 PM
marketbeat.com logoShort Interest in Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Declines By 6.6%
marketbeat.com - February 17 at 9:26 AM
Get Alpine Immune Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for ALPN and its competitors with MarketBeat's FREE daily newsletter.



ALPN Media Mentions By Week

ALPN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ALPN
News Sentiment
▼
1.89

0.68
▲
Average
Medical
News Sentiment

ALPN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ALPN Articles
This Week
▼
1

1
▲
ALPN Articles
Average Week

Get Alpine Immune Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for ALPN and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:ALPN) was last updated on 9/30/2023 by MarketBeat.com Staff

My Account -